RESPONSE BIOMEDICAL CORP Proceeds from Common Stock Issued
RESPONSE BIOMEDICAL CORP reported Proceeds from Common Stock Issued of CAD 2.06 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2014-03-17
- RESPONSE BIOMEDICAL CORP proceeds from issuance of common stock for the quarter ending 2011-12-31 was 6.04M CAD.
- RESPONSE BIOMEDICAL CORP proceeds from issuance of common stock for fiscal 2013 was 2.06M CAD.
- RESPONSE BIOMEDICAL CORP proceeds from issuance of common stock for fiscal 2011 was 2.33M CAD, a 70.30% decline from fiscal 2010.
- RESPONSE BIOMEDICAL CORP proceeds from issuance of common stock for fiscal 2010 was 7.85M CAD, a 31.10% decline from fiscal 2009.
- RESPONSE BIOMEDICAL CORP proceeds from issuance of common stock for fiscal 2009 was 11.39M CAD.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|
| 2013-12-31 | 2.06M CAD 10-K · filed 2014-03-17 | |||
| 2011-12-31 | 6.04M CAD 10-Q · filed 2012-11-14 | 2.33M CAD 10-K · filed 2014-03-17 | 2.33M CAD 10-K · filed 2012-03-29 | |
| 2011-12-29 | 6.72M CAD 10-Q · filed 2013-11-13 | |||
| 2010-12-31 | 7.85M CAD 10-K · filed 2013-03-15 | |||
| 2009-12-31 | 11.39M CAD 10-K · filed 2012-03-29 |